Karyopharm Therapeutics Inc (KPTI)
1.06
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
1.05
-0.01
(-0.94%)
After-Hours: 20:00
Karyopharm Therapeutics Cash from Financing (Quarterly): 0.264M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.264M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.86M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 155.84M |
| September 30, 2022 | 5.799M |
| June 30, 2022 | 1.313M |
| March 31, 2022 | 30.78M |
| December 31, 2021 | 0.896M |
| September 30, 2021 | 0.016M |
| June 30, 2021 | 62.06M |
| March 31, 2021 | 10.68M |
| December 31, 2020 | 3.968M |
| September 30, 2020 | 1.24M |
| June 30, 2020 | 2.046M |
| March 31, 2020 | 164.83M |
| December 31, 2019 | 34.94M |
| September 30, 2019 | 88.82M |
| June 30, 2019 | 0.395M |
| March 31, 2019 | 0.152M |
| December 31, 2018 | 167.78M |
| September 30, 2018 | 0.772M |
| Date | Value |
|---|---|
| June 30, 2018 | 147.13M |
| March 31, 2018 | 0.429M |
| December 31, 2017 | 22.96M |
| September 30, 2017 | 0.16M |
| June 30, 2017 | 52.57M |
| March 31, 2017 | 0.057M |
| December 31, 2016 | 19.25M |
| September 30, 2016 | 31.48M |
| June 30, 2016 | 0.24M |
| March 31, 2016 | 0.196M |
| December 31, 2015 | 1.484M |
| September 30, 2015 | 0.039M |
| June 30, 2015 | 0.017M |
| March 31, 2015 | 91.16M |
| December 31, 2014 | 0.149M |
| September 30, 2014 | 113.34M |
| June 30, 2014 | -0.38M |
| March 31, 2014 | 0.013M |
| December 31, 2013 | 113.16M |
| September 30, 2013 | 44.18M |
| June 30, 2013 | 23.06M |
| March 31, 2013 | 5.53M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2023
164.83M
Maximum
Mar 2020
29.72M
Average
2.046M
Median
Jun 2020
Cash from Financing (Quarterly) Benchmarks
| Geron Corp | 33.28M |
| Arbutus Biopharma Corp | 3.807M |
| Verastem Inc | -0.446M |
| Actinium Pharmaceuticals Inc | 1.192M |
| Chimerix Inc | 0.062M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.58M |
| Cash from Investing (Quarterly) | 26.84M |
| Free Cash Flow | -92.72M |
| Free Cash Flow Per Share (Quarterly) | -0.1619 |
| Free Cash Flow to Equity (Quarterly) | -18.80M |
| Free Cash Flow to Firm (Quarterly) | -14.89M |
| Free Cash Flow Yield | -76.59% |